MedTrace Logo

Safety and Feasibility of Reversible Induction Strategy

NCT04434963 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-09-14

No results posted yet for this study

Summary

This study would explore the safety and feasibility of a reversible induction strategy for uncertain difficult airway. This reversible induction strategy would include high flow nasal canular oxygenation support, short-term effect anesthetic including Propofol and Remifentanil for sedation and analgesia and Sugammadex would be used for reverse the muscle relaxant.

Conditions

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • diansan su · Renji Hospital, Shanghai Jiaotong University, Shanghai, China

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04434963 on ClinicalTrials.gov